# Evaluation of ColdZyme® Mouth Spray on Prevention and Alleviation of Rhinovirus Induced Common Cold

> **NCT02522949** · NA · COMPLETED · sponsor: **Enzymatica AB** · enrollment: 46 (actual)

## Conditions studied

- Common Cold

## Interventions

- **DEVICE:** ColdZyme® mouth spray
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT02522949
- **Lead sponsor:** Enzymatica AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02522949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02522949, "Evaluation of ColdZyme® Mouth Spray on Prevention and Alleviation of Rhinovirus Induced Common Cold". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02522949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*